Related Experiment Video
Updated: Jun 23, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Current approaches to renovascular hypertension
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA. textor.stephen@mayo.edu
This review covers renovascular hypertension, focusing on prevalence, mechanisms, and management. It highlights renal artery stenosis (RAS) as a key factor requiring careful monitoring and treatment considerations.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Background:
- Renovascular hypertension is a complex condition requiring integrated clinical approaches.
- Renal artery stenosis (RAS) is a significant cause of secondary hypertension.
- RAS is an atherosclerotic vascular complication necessitating ongoing management.
Purpose of the Study:
- To provide an updated overview of renovascular hypertension.
- To discuss the prevalence, mechanisms, clinical manifestations, and management strategies.
- To emphasize the importance of managing RAS as a progressive vascular disease.
Main Methods:
- Literature review and synthesis of current knowledge.
- Analysis of clinical features and diagnostic approaches.
- Discussion of therapeutic options, including revascularization.
Main Results:
- Renovascular hypertension requires individualized patient assessment.
- Management involves addressing both hypertension and the underlying RAS.
- Progression of RAS and ischemic injury are critical factors in treatment decisions.
Conclusions:
- Effective management of renovascular hypertension hinges on understanding RAS progression.
- Revascularization timing is determined by disease severity and patient factors.
- Atherosclerotic RAS shares similarities with other progressive vascular diseases like aneurysms.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Vasodilators
